Defending the family

Share on MeWe Share on Gab E-mail article

Are Obama Pro-Death Policies Striking At Sick Americans Now?

Public Advocate President Eugene Delgaudio asks: is President Obama's Federal Drug Administration "Death Squads" visiting sick Americans and denying them medicine on a grand scale. Or is it just an unfortunate, coincidental occurence that there is a massive drug shortage for only life preserving cures that were routinely available just a few months ago?

Delgaudio asks "I give a shout out to the muckrakers, the conservative journalists, the Michele Malkins and Sean Hannities that investigate and break the "code" of this "mystery". And if Obama's appointees at the FDA are simply and directly squeezing the drug manufacturers to rush the deaths of Americans, then Congress needs to get their act together with hearings on an urgent basis."

ABC TV news reported months ago that drugs for life ending illnesses are scarcest they have been "in decades".

Many hospital patients are being turned away for potentially life-saving injection treatments in what may be the largest U.S. hospital drug shortage in over two decades.

Most drugs in short supply are known as injectables and include sedation medication such as propofol, the popular blood thinner heparin, and hard-hitting chemotherapy drugs like doxorubicin.

"I've been in practice more than 30 years and this is the first time I've encountered shortages that may affect patient care," said Dr. Michael Link, president-elect of the American Society of Clinical Oncology.

The article reports of one patient with cancer getting a fraction of his previous treatment when a full dose of medicine was working against the cancer.

Read "The government's set to worsen our shortage of life-saving medications"

Pajamas says "the shortages are in various injectable drugs typically administered to seriously ill patients in hospitals."

In a detailed critique of the FDA, pharmaceutical industry writer Stella Daily Zawistowski observes that the FDA drug approval process currently costs companies approximately $800 million

ABC NewsU.S. Facing Largest Hospital Drug Shortage in Decades